支气管动脉灌注化疗和栓塞化疗治疗肺癌的效果  

Effect of Bronchial Artery Infusion Chemotherapy and Embolization Chemotherapy on Lung Cancer

作　　者：林勇[1] 赖嘉华 吴陈辉 黄海[1] LIN Yong;LAI Jia-hua;WU Chen-hui;HUANG Hai(Department of Thoracic Surgery,Fuzhou Second Hospital,Fuzhou,Fujian Province,350007 China;Emergency Department,Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou,Guangdong Province,510000 China)

机构地区：[1]福州市第二医院胸外科,福建福州350007 [2]广州中医药大学第二附属医院急诊科,广东广州510000

出　　处：《中外医疗》2019年第30期53-55,共3页China & Foreign Medical Treatment

摘　　要：目的探讨对肺癌患者选择支气管动脉灌注化疗+栓塞化疗方法治疗后获得的临床效果。方法方便选择该院2015年11月—017年2月收治的143例肺癌患者作为实验对象;数字奇偶法分组后探究每组化疗策略;比照组(71例):选择支气管动脉灌注化疗策略施治;实验组(72例):选择支气管动脉灌注化疗+栓塞化疗策略施治;比较两组肺癌患者病症治疗总缓解率、化疗不良反应发生率。结果实验组完全缓解患者55例(76.39%);部分缓解患者13例(18.06%);稳定患者2例(2.78%);进展患者2例(2.78%),总缓解患者68例(94.44%)高于比照组(77.46%),差异有统计学意义(χ^2=8.567,P<0.05);实验组肺癌患者化疗不良反应发生率(15.28%)同比照组(14.08%)比较差异无统计学意义(χ^2=0.041,P>0.05)。结论肺癌患者于临床接受支气管动脉灌注化疗+栓塞化疗治疗后,对于病症治疗总缓解率提升,效果显著,最终对于肺癌患者病情好转以及综合康复状态的提升,奠定基础。Objective To investigate the clinical effects of bronchial arterial infusion chemotherapy+embolization chemotherapy in patients with lung cancer.Methods A total of 143 patients with lung cancer admitted to the hospital from November 2015 to February 2017 were convenient selected as subjects.The digital parity method was used to analyze each group of chemotherapy strategies.The comparison group(71 cases):the choice of bronchial arterial infusion chemotherapy strategy;the experimental group(72 cases):bronchial arterial infusion chemotherapy+embolization chemotherapy strategy was selected;the total remission rate and the incidence of chemotherapy adverse reactions were compared between the two groups of lung cancer patients.Results In the experimental group,55 patients(76.39%)were completely relieved;13 patients(18.06%)were partially relieved;2 patients(2.78%)were stable;2 patient(2.78%)was progressive,and 68 patients(94.44%)were remission,higher than the comparison group(77.46%),the difference was statistically significant(χ^2=8.567,P<0.05);the experimental group of lung cancer patients with adverse reactions to chemotherapy occurrance rate(15.28%)was not statistically significant,compared with that in the control group(14.08%)(χ^2=0.041,P>0.05).Conclusion After receiving bronchial arterial infusion chemotherapy+embolization chemotherapy,the patients with lung cancer have a significant effect on the overall remission rate of the disease treatment.The results are significant,and finally lay a foundation for the improvement of lung cancer patients and the improvement of comprehensive rehabilitation status.

关 键 词：支气管动脉灌注化疗 栓塞化疗 肺癌 临床效果 

分 类 号：R734.2[医药卫生—肿瘤]